Literature DB >> 24799466

Principles of opioid use in cancer pain.

Russell K Portenoy1, Ebtesam Ahmed2.   

Abstract

The management of pain is an essential aspect of comprehensive cancer care. Positive outcomes can be achieved in most patients with widely available therapies. There is a broad consensus that opioid-based pharmacotherapy is the first-line strategy for the treatment of moderate or severe chronic pain in populations with active disease, and treatment guidelines have been developed from the known pharmacology of these drugs, extant data, and extensive clinical experience. This article describes the major opioid analgesics available for the treatment of cancer-related pain and reviews the key elements for safe and effective prescribing, including selection of the best drug and route, approaches to titration and long-term administration of baseline and supplemental doses, rotation from one drug to another in poorly responsive patients, and management of opioid risks.
© 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24799466     DOI: 10.1200/JCO.2013.52.5188

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  25 in total

1.  Opioid Wisely.

Authors:  Leonie Herx
Journal:  CMAJ       Date:  2019-03-04       Impact factor: 8.262

Review 2.  Genetic Variants Associated with Cancer Pain and Response to Opioid Analgesics: Implications for Precision Pain Management.

Authors:  Gee Su Yang; Natalie M Barnes; Debra E Lyon; Susan G Dorsey
Journal:  Semin Oncol Nurs       Date:  2019-05-10       Impact factor: 2.315

3.  [Side effects of pain therapy : Sufficient analgesia without unnecessary complications].

Authors:  F Greul; A Zimmer; W Meißner
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

4.  BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.

Authors:  Ning Li; Zheng-Lan Han; Zi-Long Wang; Yan-Hong Xing; Yu-Long Sun; Xu-Hui Li; Jing-Jing Song; Ting Zhang; Run Zhang; Meng-Na Zhang; Biao Xu; Quan Fang; Rui Wang
Journal:  Br J Pharmacol       Date:  2016-04-21       Impact factor: 8.739

5.  Pain in cancer patients: pain assessment by patients and family caregivers and problems experienced by caregivers.

Authors:  Özlem Ovayolu; Nimet Ovayolu; Sema Aytaç; Sibel Serçe; Alper Sevinc
Journal:  Support Care Cancer       Date:  2014-12-05       Impact factor: 3.603

Review 6.  Longitudinal K-means approaches to clustering and analyzing EHR opioid use trajectories for clinical subtypes.

Authors:  Sarah Mullin; Jaroslaw Zola; Robert Lee; Jinwei Hu; Brianne MacKenzie; Arlen Brickman; Gabriel Anaya; Shyamashree Sinha; Angie Li; Peter L Elkin
Journal:  J Biomed Inform       Date:  2021-08-16       Impact factor: 8.000

7.  Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies.

Authors:  Dylan Zylla; Grant Steele; Alice Shapiro; Sara Richter; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2018-02-02       Impact factor: 3.603

8.  Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.

Authors:  Ahsan Azhar; Yu Jung Kim; Ali Haider; David Hui; Vishidha R Balankari; Margeaux Chiou Epner; Minjeong Park; Diane D Liu; Janet Williams; Susan E Frisbee-Hume; Julio A Allo; Eduardo Bruera
Journal:  Oncologist       Date:  2018-09-25

9.  Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors.

Authors:  Lucas K Vitzthum; Paul Riviere; Paige Sheridan; Vinit Nalawade; Rishi Deka; Timothy Furnish; Loren K Mell; Brent Rose; Mark Wallace; James D Murphy
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

10.  Changes in use of opioid therapy after colon cancer diagnosis: a population-based study.

Authors:  Lu Chen; Jessica Chubak; Onchee Yu; Gaia Pocobelli; Rebecca A Ziebell; Erin J Aiello Bowles; Monica M Fujii; Andrew T Sterrett; Jennifer M Boggs; Andrea N Burnett-Hartman; Debra P Ritzwoller; Rebecca A Hubbard; Denise M Boudreau
Journal:  Cancer Causes Control       Date:  2019-10-30       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.